サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1233404

注意欠陥多動性障害治療の世界市場：神経精神疾患の有病率の増加により、ADHD治療の研究が世界的に促進される

Growing Prevalence of Neuropsychiatric Disorders has Propelled Research in ADHD Therapeutics Globally
出版日: | 発行: Persistence Market Research | ページ情報: 英文 250 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
注意欠陥多動性障害治療の世界市場：神経精神疾患の有病率の増加により、ADHD治療の研究が世界的に促進される
出版日: 2023年01月10日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の注意欠陥多動性障害治療市場を調査し、市場の構造に関する詳細情報とともに、促進要因、動向、機会、抑制要因、競合情勢など、主要な市場力学についての詳細な評価と、2023年から2033年の予測期間中の予測を掲載しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類法
  • 市場の定義/範囲/制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 市場の革新/開発動向

第4章 主要な成功要因

  • 薬剤の採用/使用分析
  • 疾病疫学
  • 償還シナリオ
  • パイプライン分析
  • バリューチェーン分析
  • 主要な規制シナリオ
  • PESTEL分析
  • ポーターの分析

第5章 市場の背景

  • マクロ経済要因
    • 世界のGDP成長の見通し
    • 世界のヘルスケアの見通し
    • 世界の神経疾患薬市場概要
  • 予測要因：関連性と影響
    • 疾患の進行に対するライフスタイルの影響
    • 神経疾患および神経精神疾患に対する意識の高まり
    • 世界的に広がる疾患の有病率
    • 新薬開発のための研究開発努力の高まり
    • 治療法の利用可能性
    • ADHDの病因に対する遺伝的影響の確立
    • 治療費
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会分析

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
    • 国別
  • 2022年の市場シナリオ

第7章 世界の注意欠陥多動性障害治療市場：需要分析・予測

  • 過去の市場分析
  • 現在および将来の市場予測
    • 前年比成長動向分析

第8章 世界の注意欠陥多動性障害治療市場の分析・予測：薬剤別

  • イントロダクション/主要な調査結果
  • 過去の市場分析：薬剤別
  • 現在および将来の市場分析・予測：薬剤別
    • 刺激性
    • 非刺激性
  • 市場魅力分析：薬剤別

第9章 世界の注意欠陥多動性障害治療市場の分析・予測：年齢層別

  • イントロダクション/主要な調査結果
  • 過去の市場分析：年齢層別
  • 現在および将来の市場分析・予測：年齢層別
    • 小児・思春期
    • 大人
  • 市場魅力分析：年齢層別

第10章 世界の注意欠陥多動性障害治療市場の分析・予測：流通チャネル別

  • イントロダクション/主要な調査結果
  • 過去の市場分析：流通チャネル別
  • 現在および将来の市場分析・予測：流通チャネル別
    • 専門診療所
    • 病院薬局
    • 小売薬局
    • eコマース
  • 市場魅力分析：流通チャネル別

第11章 世界の注意欠陥多動性障害治療市場の分析・予測：地域別

  • イントロダクション
  • 過去の市場分析：地域別
  • 現在および将来の市場分析・予測
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 市場魅力分析：地域別

第12章 北米の注意欠陥多動性障害治療市場：分析・予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析・予測
    • 国別
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
  • 市場魅力分析
    • 国別
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因：影響分析
  • 主要企業：強度マッピング
  • 国レベルの分析・予測
    • 米国の注意欠陥多動性障害治療市場分析
    • カナダの注意欠陥多動性障害治療市場分析

第13章 ラテンアメリカの注意欠陥多動性障害治療市場：分析・予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析・予測
    • 国別
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
  • 市場魅力分析
    • 国別
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因：影響分析
  • 主要企業：強度マッピング
  • 国レベルの分析・予測
    • メキシコの注意欠陥多動性障害治療市場分析
    • ブラジルの注意欠陥多動性障害治療市場分析
    • アルゼンチンの注意欠陥多動性障害治療市場分析

第14章 欧州の注意欠陥多動性障害治療市場：分析・予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析・予測
    • 国別
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
  • 市場魅力分析
    • 国別
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因：影響分析
  • 主要企業：強度マッピング
  • 国レベルの分析・予測
    • ドイツの注意欠陥多動性障害治療市場分析
    • イタリアの注意欠陥多動性障害治療市場分析
    • フランスの注意欠陥多動性障害治療市場分析
    • 英国の注意欠陥多動性障害治療市場分析
    • スペインの注意欠陥多動性障害治療市場分析
    • ベネルクス諸国の注意欠陥多動性障害治療市場分析
    • ロシアの注意欠陥多動性障害治療市場分析

第15章 東アジアの注意欠陥多動性障害治療市場：分析・予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析・予測
    • 国別
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
  • 市場魅力分析
    • 国別
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因：影響分析
  • 主要企業：強度マッピング
  • 国レベルの分析・予測
    • 中国の注意欠陥多動性障害治療市場分析
    • 日本の注意欠陥多動性障害治療市場分析
    • 韓国の注意欠陥多動性障害治療市場分析

第16章 南アジアの注意欠陥多動性障害治療市場：分析・予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析・予測
    • 国別
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
  • 市場魅力分析
    • 国別
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因：影響分析
  • 主要企業：強度マッピング
  • 国レベルの分析・予測
    • インドの注意欠陥多動性障害治療市場分析
    • インドネシアの注意欠陥多動性障害治療市場分析
    • マレーシアの注意欠陥多動性障害治療市場分析
    • タイの注意欠陥多動性障害治療市場分析

第17章 オセアニアの注意欠陥多動性障害治療の市場と予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析・予測
    • 国別
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
  • 市場魅力分析
    • 国別
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因：影響分析
  • 主要企業：強度マッピング
  • 国レベルの分析・予測
    • オーストラリアの注意欠陥多動性障害治療市場分析
    • ニュージーランドの注意欠陥多動性障害治療市場分析

第18章 中東・アフリカの注意欠陥多動性障害治療市場の分析・予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析・予測
    • 国別
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
  • 市場魅力分析
    • 国別
    • 薬剤別
    • 年齢層別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因：影響分析
  • 主要企業：強度マッピング
  • 国レベルの分析・予測
    • GCC諸国の注意欠陥多動性障害治療市場分析
    • トルコの注意欠陥多動性障害治療市場分析
    • 南アフリカの注意欠陥多動性障害治療市場分析
    • 北アフリカの注意欠陥多動性障害治療市場分析

第19章 市場構造分析

  • 市場分析：企業層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Pfizer Inc.
    • Eli Lilly and Company
    • Novartis AG
    • GlaxoSmithKline PLC
    • Mallinckrodt Pharmaceuticals
    • Hisamitsu Pharmaceutical Co., Inc.
    • Johnson & Johnson
    • UCB S.A.
    • Purdue Pharma L.P.

第21章 前提条件と頭字語

第22章 調査手法

図表

List of Tables

  • Table 01: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033, by Drug
  • Table 02: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033, by Age Group
  • Table 03: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
  • Table 04: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033, by Region
  • Table 05: North America Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 06: North America Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug
  • Table 07: North America Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Age Group
  • Table 08: North America Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
  • Table 09: Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 10: Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug
  • Table 11: Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Age Group
  • Table 12: Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
  • Table 13: Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 14: Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug
  • Table 15: Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033by Age Group
  • Table 16: Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
  • Table 17: East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 18: East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug
  • Table 19: East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Age Group
  • Table 20: East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
  • Table 21: South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 22: South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug
  • Table 23: South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Age Group
  • Table 24: South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
  • Table 25: Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 26: Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug
  • Table 27: Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033by Age Group
  • Table 28: Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
  • Table 29: Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 30: Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug
  • Table 31: Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033by Age Group
  • Table 32: Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel

List of Figures

  • Figure 01: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 02: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Forecast & Y-o-Y Growth, 2023-2033
  • Figure 03: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Absolute $ Opportunity (US$ Mn) Analysis, 2022-2033
  • Figure 04: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share (%) Analysis 2023 and 2033, by Drug
  • Figure 05: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Y-o-Y Growth (%) Analysis 2022-2033, by Drug
  • Figure 06: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis 2023-2033, by Drug
  • Figure 07: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share (%) Analysis 2023 and 2033, by Age Group
  • Figure 08: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Y-o-Y Growth (%) Analysis 2022-2033, by Age Group
  • Figure 09: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis 2023-2033, by Age Group
  • Figure 10: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share (%) Analysis 2023 and 2033, by Distribution Channel
  • Figure 11: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Y-o-Y Growth (%) Analysis 2022-2033, by Distribution Channel
  • Figure 12: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis 2023-2033, by Distribution Channel
  • Figure 13: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share (%) Analysis 2023 and 2033, by Region
  • Figure 14: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
  • Figure 15: Global Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis 2023-2033, by Region
  • Figure 16: North America Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 17: North America Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 18: North America Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Drug (2023 E)
  • Figure 19: North America Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Age Group (2023 E)
  • Figure 20: North America Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Distribution Channel (2023 E)
  • Figure 21: North America Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Country (2023 E)
  • Figure 22: North America Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Drug, 2023-2033
  • Figure 23: North America Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Age Group, 2023-2033
  • Figure 24: North America Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 25: North America Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Country, 2023-2033
  • Figure 26: U.S. Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 27: Global Vs. U.S. Growth Comparison
  • Figure 28: U.S. Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 29: U.S. Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 30: U.S. Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 31: Canada Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 32: Global Vs. Canada. Growth Comparison
  • Figure 33: Canada Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 34: Canada Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 35: Canada Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 36: Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 37: Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 38: Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Drug (2023 E)
  • Figure 39: Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Age Group (2023 E)
  • Figure 40: Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Distribution Channel (2023 E)
  • Figure 41: Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Country (2023 E)
  • Figure 42: Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Drug, 2023-2033
  • Figure 43: Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Age Group, 2023-2033
  • Figure 44: Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 45: Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Country, 2023-2033
  • Figure 46: Mexico Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 47: Global Vs Mexico Growth Comparison
  • Figure 48: Mexico Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 49: Mexico Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 50: Mexico Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 51: Brazil Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 52: Global Vs. Brazil. Growth Comparison
  • Figure 53: Brazil Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 54: Brazil Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 55: Brazil Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 56: Argentina Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 57: Global Vs Argentina Growth Comparison
  • Figure 58: Argentina Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 59: Argentina Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 60: Argentina Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 61: Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 62: Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 63: Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Drug (2023 E)
  • Figure 64: Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Age Group (2023 E)
  • Figure 65: Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Distribution Channel (2023 E)
  • Figure 66: Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Country (2023 E)
  • Figure 67: Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Drug, 2023-2033
  • Figure 68: Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Age Group, 2023-2033
  • Figure 69: Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 70: Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Country, 2023-2033
  • Figure 71: UK Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 72: Global Vs. UK Growth Comparison
  • Figure 73: UK Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 74: UK Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 75: UK Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 76: Germany Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 77: Global Vs. Germany Growth Comparison
  • Figure 78: Germany Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 79: Germany Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 80: Germany Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 81: Italy Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 82: Global Vs. Italy Growth Comparison
  • Figure 83: Italy Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 84: Italy Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 85: Italy Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 86: France Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 87: Global Vs France Growth Comparison
  • Figure 88: France Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 89: France Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 90: France Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 91: Spain Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 92: Global Vs Spain Growth Comparison
  • Figure 93: Spain Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 94: Spain Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 95: Spain Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 96: Russia Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 97: Global Vs Russia Growth Comparison
  • Figure 98: Russia Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 99: Russia Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 100: Russia Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 101: BENELUX Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 102: Global Vs BENELUX Growth Comparison
  • Figure 103: BENELUX Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 104: BENELUX Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 105: BENELUX Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 106: East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 107: East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 108: East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Drug (2023 E)
  • Figure 109: East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Age Group (2023 E)
  • Figure 110: East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Distribution Channel (2023 E)
  • Figure 111: East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Country (2023 E)
  • Figure 112: East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Drug, 2023-2033
  • Figure 113: East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Age Group, 2023-2033
  • Figure 114: East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 115: East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Country, 2023-2033
  • Figure 116: China Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 117: Global Vs. China Growth Comparison
  • Figure 118: China Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 119: China Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 120: China Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 121: Japan Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 122: Global Vs. Japan Growth Comparison
  • Figure 123: Japan Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 124: Japan Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 125: Japan Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 126: South Korea Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 127: Global Vs South Korea Growth Comparison
  • Figure 128: South Korea Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 129: South Korea Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 130: South Korea Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 131: South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 132: South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 133: South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Drug (2023 E)
  • Figure 134: South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Age Group (2023 E)
  • Figure 135: South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Distribution Channel (2023 E)
  • Figure 136: South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Country (2023 E)
  • Figure 137: South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Drug, 2023-2033
  • Figure 138: South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Age Group, 2023-2033
  • Figure 139: South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 140: South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Country, 2023-2033
  • Figure 141: India Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 142: Global Vs. India Growth Comparison
  • Figure 143: India Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 144: India Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 145: India Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 146: Indonesia Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 147: Global Vs. Indonesia Growth Comparison
  • Figure 148: Indonesia Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 149: Indonesia Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 150: Indonesia Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 151: Malaysia Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 152: Global Vs. Malaysia Growth Comparison
  • Figure 153: Malaysia Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 154: Malaysia Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 155: Malaysia Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 156: Thailand Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 157: Global Vs. Thailand Growth Comparison
  • Figure 158: Thailand Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 159: Thailand Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 160: Thailand Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 161: Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 162: Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 163: Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Drug (2023 E)
  • Figure 164: Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Age Group (2023 E)
  • Figure 165: Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Distribution Channel (2023 E)
  • Figure 166: Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Country (2023 E)
  • Figure 167: Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Drug, 2023-2033
  • Figure 168: Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Age Group, 2023-2033
  • Figure 169: Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 170: Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Country, 2023-2033
  • Figure 171: Australia Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 172: Global Vs. Australia Growth Comparison
  • Figure 173: Australia Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 174: Australia Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 175: Australia Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 176: New Zealand Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 177: Global Vs New Zealand Growth Comparison
  • Figure 178: New Zealand Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 179: New Zealand Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 180: New Zealand Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 181: Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 182: Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 183: Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Drug (2023 E)
  • Figure 184: Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Age Group (2023 E)
  • Figure 185: Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Distribution Channel (2023 E)
  • Figure 186: Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Value Share, by Country (2023 E)
  • Figure 187: Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Drug, 2023-2033
  • Figure 188: Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Age Group, 2023-2033
  • Figure 189: Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 190: Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Attractiveness Analysis by Country, 2023-2033
  • Figure 191: GCC Countries Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 192: Global Vs GCC Countries Growth Comparison
  • Figure 193: GCC Countries Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 194: GCC Countries Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 195: GCC Countries Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 196: Turkey Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 197: Global Vs. Turkey Growth Comparison
  • Figure 198: Turkey Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 199: Turkey Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 200: Turkey Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 201: South Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 202: Global Vs. South Africa Growth Comparison
  • Figure 203: South Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 204: South Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 205: South Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 206: North Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Value Proportion Analysis, 2022
  • Figure 207: Global Vs North Africa Growth Comparison
  • Figure 208: North Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Drug, 2022 & 2033
  • Figure 209: North Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Age Group, 2022 & 2033
  • Figure 210: North Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Share Analysis (%) by Distribution Channel, 2022 & 2033
目次
Product Code: PMRREP4222

Attention Deficit Hyperactivity Disorder Therapeutics Market: Scope of the Report

The latest publication by Persistence Market Research on the global attention deficit hyperactivity disorder therapeutics market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023 - 2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for attention deficit hyperactivity disorder therapeutics market drugs and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the attention deficit hyperactivity disorder therapeutics market. Shareholders in the attention deficit hyperactivity disorder therapeutics market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the attention deficit hyperactivity disorder therapeutics market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the attention deficit hyperactivity disorder therapeutics market offers information divided into four important segments - drug, age group, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug

Stimulants

Amphetamine

Methylphenidate

Dextroamphetamine

Dexmethylphenidate

Lisdexamfetamine Dimesylate

Non-stimulants

Atomoxetine

Bupropion

Guanfacine

Clonidine

Age Group

Pediatric and Adolescent

Adults

Distribution Channel

Specialty Clinics

Hospital Pharmacies

Retail Pharmacies

e-Commerce

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa (MEA)

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for attention deficit hyperactivity disorder therapeutics over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the attention deficit hyperactivity disorder therapeutics market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the attention deficit hyperactivity disorder therapeutics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, drug portfolio managers, CEOs, VPs, marketing/drug managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research's projections on the growth prospects of the attention deficit hyperactivity disorder therapeutics market are more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Market Innovation / Development Trends

4. Key Success Factors

  • 4.1. Drug Adoption/Usage Analysis
  • 4.2. Disease Epidemiology
  • 4.3. Reimbursement Scenario
  • 4.4. Pipeline Analysis
  • 4.5. Value Chain Analysis
  • 4.6. Key Regulatory Scenario
  • 4.7. PESTEL Analysis
  • 4.8. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Neurological Disorder Drugs Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Impact of Lifestyle on Disease Progression
    • 5.2.2. Rising Awareness on Neurological and Neuropsychiatric Disorders
    • 5.2.3. Growing Disease Prevalence Globally
    • 5.2.4. Rising R&D Efforts for Novel Drug Development
    • 5.2.5. Availability of Treatment Modalities
    • 5.2.6. Established Genetic Impact on the Etiology of ADHD
    • 5.2.7. Cost of Treatment
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Drug
    • 6.1.2. By Age Group
    • 6.1.3. By Distribution Channel
    • 6.1.4. By Country
  • 6.2. 2022 Market Scenario

7. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Demand (in Value or Size in US$ Mn) Analysis 2015-2022 and Forecast, 2023-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2022
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033, By Drug

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Drug, 2015-2022
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug, 2023-2033
    • 8.3.1. Stimulants
      • 8.3.1.1. Amphetamine
      • 8.3.1.2. Methylphenidate
      • 8.3.1.3. Dextroamphetamine
      • 8.3.1.4. Dexmethylphenidate
      • 8.3.1.5. Lisdexamfetamine Dimesylate
    • 8.3.2. Non-stimulants
      • 8.3.2.1. Atomoxetine
      • 8.3.2.2. Bupropion
      • 8.3.2.3. Guanfacine
      • 8.3.2.4. Clonidine
  • 8.4. Market Attractiveness Analysis By Drug

9. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033, By Age Group

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Age Group, 2015-2022
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Age Group, 2023-2033
    • 9.3.1. Pediatric and Adolescent
    • 9.3.2. Adults
  • 9.4. Market Attractiveness Analysis By Age Group

10. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033, By Distribution Channel

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2015-2022
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2023-2033
    • 10.3.1. Specialty Clinics
    • 10.3.2. Hospital Pharmacies
    • 10.3.3. Retail Pharmacies
    • 10.3.4. E-Commerce
  • 10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2022
  • 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Drug
    • 12.3.3. By Age Group
    • 12.3.4. By Distribution Channel
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Drug
    • 12.4.3. By Age Group
    • 12.4.4. By Distribution Channel
  • 12.5. Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Key Players - Intensity Mapping
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Drug
        • 12.8.1.2.2. By Age Group
        • 12.8.1.2.3. By Distribution Channel
    • 12.8.2. Canada Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Drug
        • 12.8.2.2.2. By Age Group
        • 12.8.2.2.3. By Distribution Channel

13. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Drug
    • 13.3.3. By Age Group
    • 13.3.4. By Distribution Channel
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Drug
    • 13.4.3. By Age Group
    • 13.4.4. By Distribution Channel
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Key Players - Intensity Mapping
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Mexico Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Drug
        • 13.8.1.2.2. By Age Group
        • 13.8.1.2.3. By Distribution Channel
    • 13.8.2. Brazil Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Drug
        • 13.8.2.2.2. By Age Group
        • 13.8.2.2.3. By Distribution Channel
    • 13.8.3. Argentina Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Drug
        • 13.8.3.2.2. By Age Group
        • 13.8.3.2.3. By Distribution Channel

14. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Drug
    • 14.3.3. By Age Group
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Drug
    • 14.4.3. By Age Group
    • 14.4.4. By Distribution Channel
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Germany Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Drug
        • 14.8.1.2.2. By Age Group
        • 14.8.1.2.3. By Distribution Channel
    • 14.8.2. Italy Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Drug
        • 14.8.2.2.2. By Age Group
        • 14.8.2.2.3. By Distribution Channel
    • 14.8.3. France Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Drug
        • 14.8.3.2.2. By Age Group
        • 14.8.3.2.3. By Distribution Channel
    • 14.8.4. U.K. Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.4.2.1. By Drug
        • 14.8.4.2.2. By Age Group
        • 14.8.4.2.3. By Distribution Channel
    • 14.8.5. Spain Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 14.8.5.1. Introduction
      • 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.5.2.1. By Drug
        • 14.8.5.2.2. By Age Group
        • 14.8.5.2.3. By Distribution Channel
    • 14.8.6. BENELUX Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 14.8.6.1. Introduction
      • 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.6.2.1. By Drug
        • 14.8.6.2.2. By Age Group
        • 14.8.6.2.3. By Distribution Channel
    • 14.8.7. Russia Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 14.8.7.1. Introduction
      • 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.7.2.1. By Drug
        • 14.8.7.2.2. By Age Group
        • 14.8.7.2.3. By Distribution Channel

15. East Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Drug
    • 15.3.3. By Age Group
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Drug
    • 15.4.3. By Age Group
    • 15.4.4. By Distribution Channel
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. China Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Drug
        • 15.8.1.2.2. By Age Group
        • 15.8.1.2.3. By Distribution Channel
    • 15.8.2. Japan Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Drug
        • 15.8.2.2.2. By Age Group
        • 15.8.2.2.3. By Distribution Channel
    • 15.8.3. South Korea Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Drug
        • 15.8.3.2.2. By Age Group
        • 15.8.3.2.3. By Distribution Channel

16. South Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Drug
    • 16.3.3. By Age Group
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Drug
    • 16.4.3. By Age Group
    • 16.4.4. By Distribution Channel
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Drug
        • 16.8.1.2.2. By Age Group
        • 16.8.1.2.3. By Distribution Channel
    • 16.8.2. Indonesia Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Drug
        • 16.8.2.2.2. By Age Group
        • 16.8.2.2.3. By Distribution Channel
    • 16.8.3. Malaysia Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Drug
        • 16.8.3.2.2. By Age Group
        • 16.8.3.2.3. By Distribution Channel
    • 16.8.4. Thailand Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Drug
        • 16.8.4.2.2. By Age Group
        • 16.8.4.2.3. By Distribution Channel

17. Oceania Attention Deficit Hyperactivity Disorder Therapeutics Market 2015-2023 and Forecast 2023-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Drug
    • 17.3.3. By Age Group
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Drug
    • 17.4.3. By Age Group
    • 17.4.4. By Distribution Channel
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. Australia Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Drug
        • 17.8.1.2.2. By Age Group
        • 17.8.1.2.3. By Distribution Channel
    • 17.8.2. New Zealand Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Drug
        • 17.8.2.2.2. By Age Group
        • 17.8.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis 2015-2022 and Forecast 2023-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 18.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. North Africa
      • 18.3.1.4. South Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Drug
    • 18.3.3. By Age Group
    • 18.3.4. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Drug
    • 18.4.3. By Age Group
    • 18.4.4. By Distribution Channel
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Players - Intensity Mapping
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. GCC Countries Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Drug
        • 18.8.1.2.2. By Age Group
        • 18.8.1.2.3. By Distribution Channel
    • 18.8.2. Turkey Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Drug
        • 18.8.2.2.2. By Age Group
        • 18.8.2.2.3. By Distribution Channel
    • 18.8.3. South Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Drug
        • 18.8.3.2.2. By Age Group
        • 18.8.3.2.3. By Distribution Channel
    • 18.8.4. North Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Drug
        • 18.8.4.2.2. By Age Group
        • 18.8.4.2.3. By Distribution Channel

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Pfizer Inc.
      • 20.3.1.1. Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Sales Footprint
      • 20.3.1.4. Key Financials
      • 20.3.1.5. SWOT Analysis
      • 20.3.1.6. Strategy Overview
    • 20.3.2. Eli Lilly and Company
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Sales Footprint
      • 20.3.2.4. Key Financials
      • 20.3.2.5. SWOT Analysis
      • 20.3.2.6. Strategy Overview
    • 20.3.3. Novartis AG
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Sales Footprint
      • 20.3.3.4. Key Financials
      • 20.3.3.5. SWOT Analysis
      • 20.3.3.6. Strategy Overview
    • 20.3.4. GlaxoSmithKline PLC
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Sales Footprint
      • 20.3.4.4. Key Financials
      • 20.3.4.5. SWOT Analysis
      • 20.3.4.6. Strategy Overview
    • 20.3.5. Mallinckrodt Pharmaceuticals
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Sales Footprint
      • 20.3.5.4. Key Financials
      • 20.3.5.5. SWOT Analysis
      • 20.3.5.6. Strategy Overview
    • 20.3.6. Hisamitsu Pharmaceutical Co., Inc.
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Sales Footprint
      • 20.3.6.4. Key Financials
      • 20.3.6.5. SWOT Analysis
      • 20.3.6.6. Strategy Overview
    • 20.3.7. Johnson & Johnson
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Sales Footprint
      • 20.3.7.4. Key Financials
      • 20.3.7.5. SWOT Analysis
      • 20.3.7.6. Strategy Overview
    • 20.3.8. UCB S.A.
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Sales Footprint
      • 20.3.8.4. Key Financials
      • 20.3.8.5. SWOT Analysis
      • 20.3.8.6. Strategy Overview
    • 20.3.9. Purdue Pharma L.P.
      • 20.3.9.1. Overview
      • 20.3.9.2. Product Portfolio
      • 20.3.9.3. Sales Footprint
      • 20.3.9.4. Key Financials
      • 20.3.9.5. SWOT Analysis
      • 20.3.9.6. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology